These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22377744)

  • 1. Comparative monitoring of oral theophylline treatment in blood serum, saliva, and nasal mucus.
    Henkin RI
    Ther Drug Monit; 2012 Apr; 34(2):217-21. PubMed ID: 22377744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved smell function with increased nasal mucus sonic hedgehog in hyposmic patients after treatment with oral theophylline.
    Henkin RI; Hosein S; Stateman WA; Knöppel AB; Abdelmeguid M
    Am J Otolaryngol; 2017; 38(2):143-147. PubMed ID: 27923495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative resistance to oral theophylline treatment in patients with hyposmia manifested by decreased secretion of nasal mucus cyclic nucleotides.
    Henkin RI; Velicu I; Schmidt L
    Am J Med Sci; 2011 Jan; 341(1):17-22. PubMed ID: 21191261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study.
    Henkin RI; Schultz M; Minnick-Poppe L
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1064-70. PubMed ID: 23165381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic diminution of Interleukin-10 with intranasal theophylline administration in hyposmic patients.
    Hosein W; Henkin RI
    Am J Otolaryngol; 2022; 43(2):103375. PubMed ID: 35124402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between and within human parotid saliva and nasal mucus cAMP and cGMP in normal subjects and in patients with taste and smell dysfunction.
    Henkin RI; Velicu I
    J Oral Pathol Med; 2011 Jul; 40(6):504-9. PubMed ID: 21166719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 in hyposmia.
    Henkin RI; Schmidt L; Velicu I
    JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):728-34. PubMed ID: 23868430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aetiological relationships of nasal mucus cyclic nucleotides in patients with taste and smell dysfunction.
    Henkin RI; Velicu I
    J Clin Pathol; 2012 May; 65(5):447-51. PubMed ID: 22362840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label controlled trial of theophylline for treatment of patients with hyposmia.
    Henkin RI; Velicu I; Schmidt L
    Am J Med Sci; 2009 Jun; 337(6):396-406. PubMed ID: 19359985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of smell loss in patients with Type II congenital hyposmia.
    Henkin RI; Abdelmeguid M; Knöppel AB
    Am J Otolaryngol; 2016; 37(5):436-41. PubMed ID: 27221029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetic analysis of theophylline in serum and saliva.
    Trnavská Z; Rejholec V; Elis J; Spicák V
    Int J Clin Pharmacol Res; 1987; 7(5):329-35. PubMed ID: 3667005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels.
    Eney RD; Goldstein EO
    Pediatrics; 1976 Apr; 57(4):513-7. PubMed ID: 1264547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiological relationships of parotid saliva cyclic nucleotides in patients with taste and smell dysfunction.
    Henkin RI; Velicu I
    Arch Oral Biol; 2012 Jun; 57(6):670-7. PubMed ID: 22310165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal insulin: from nose to brain.
    Henkin RI
    Nutrition; 2010 Jun; 26(6):624-33. PubMed ID: 20022470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline in oral mucosal transudate. A practical method for monitoring outpatient therapy.
    Holden WE; Bartos F; Theime T; Green TR; Fitchen JH
    Am Rev Respir Dis; 1993 Mar; 147(3):739-43. PubMed ID: 8442610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary theophylline monitoring in asthmatic children.
    Orłowski L; Paczkowski D; Podleśny J
    Pol J Pharmacol Pharm; 1987; 39(2):173-6. PubMed ID: 3432165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
    Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of oral dose of oxtriphylline to serum theophylline level.
    Guyatt GH; Desai SD
    Can Med Assoc J; 1981 Dec; 125(12):1336-8. PubMed ID: 7034918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship of the theophylline concentration in the saliva and the blood serum in patients with a broncho-obstructive syndrome].
    Tsoĭ AN; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1994; 66(8):42-4. PubMed ID: 7985153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.